Navigation Links
Powersafe Technology Corp. Recapitalizes, Executes Merger Agreement with Amplification Technologies, and Invests in Amplification

VALLEY STREAM, N.Y., April 11 /PRNewswire-FirstCall/ -- Powersafe Technology Corp. (OTC Bulletin Board: "PWSF") has entered into a merger agreement with Amplification Technologies, Inc., a privately held Delaware corporation. Pursuant to the terms of the merger agreement, Amplification will merge with a wholly-owned subsidiary of Powersafe in exchange for approximately 31,500,00 shares of Powersafe to be newly issued to shareholders of Amplification and reserved for the exercise of options and conversion of convertible preferred. Powersafe will also assume approximately $700,000 of non-convertible preferred. Powersafe currently has 7,075,000 shares of common stock issued and outstanding and no other issued securities, warrants or options in its capital structure. Effective as of March 31, 2008, Jack N. Mayer, the controlling stockholder of Amplification, was appointed as a director and President of Powersafe.

Amplification is a Delaware corporation formed in May 2002 whose scientists have invented an extremely sensitive photodetector technology that it believes has significant performance and cost advantages over traditional technology and is positioned as a next generation solid state technology for low level light detection. Amplification's platform semiconductor technology, which allows amplification with very low noise of weak signals, is in principle applicable to, and has been patented to encompass, detection of signals other than light, and thus could in principle be used to create very sensitive biological, radiological, electrical, and chemical sensors. Amplification's website is

In connection with the merger agreement, a group of investors invested an aggregate of $2,000,000 in a transaction in which $625,000 was used to acquire 100% of the issued and outstanding stock of Powersafe, 95% of which was acquired by the investors, including Mr., Mayer, and 5% of which was given to persons, including Mr. Mayer, who assisted in the transaction, and approximately $1,360,000 was contributed by the new owners as capital to Powersafe. Mr. Mayer and his wife acquired approximately 27.2% of the issued and outstanding shares of Powersafe in the transaction.

Powersafe used approximately $1,280,000 to purchase non convertible Series C Preferred Stock issued by Amplification and approximately $730,000 of such proceeds were used by Amplification to redeem non-convertible preferred stock of Amplification held by Mr. Mayer and a member of his family. The Series C Preferred shares have a 2% monthly pay in kind dividend, restrictive covenants including a prohibition on funded debt and the issuance of securities which are senior or pari passu to the Series C Preferred, are redeemable by the Registrant on February 14, 2009, and are slated to be retired as part of the merger.

The closing of the merger, which is expected by the end of May, 2008, will occur when all the customary conditions in the merger agreement are satisfied, including the delivery of audited financial information of Amplification,

For more information about the transaction, see the Current Reports on Form 8-K filed by Powersafe on April 4, 9 and 11, 2008 with the Securities and Exchange Commission.

This Press Release contains forward-looking statements relating to future activity, including the closing of the merger and operational and business prospects. The Company's results may be affected by, among other factors, business abilities and judgment of personnel, availability of qualified personnel, results of the prototypes, and changes in, or failure to comply with various government regulations.

For further information, please contact Jack N. Mayer at Amplification Technologies - 718 951 8021

SOURCE Powersafe Technology Corp.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Loma Linda University Partners With Larta Institute for Technology Marketing Program
2. Slow federal action to oversee nanotechnology leaves room at the bottom
3. Genetic Engineering and Biotechnology News (GEN) Blog: International Students in the United States - A Diminishing Pool of Talent for Biotech?
4. Genetic Engineering and Biotechnology News (GEN) Presents Exclusive Podcast with Robert Langer, Ph.D. on New Polymeric Drug Delivery Systems
5. HemoGenix(R), Inc. Receives Issued Patent for its HALO(R) Technology Platform From the United States Patent and Trademark Office (USPTO).
6. Sangamo BioSciences Announces License Agreement For the Use of ZFP Technology For Generation of Transgenic Animals
7. Nanosized technology has supersized effect on tumors
8. Hybrid computer materials may lead to faster, cheaper technology
9. Raven biotechnologies and Bioprocessing Technology Institute Announce Collaboration to Advance Discovery of Stem Cell Antibodies
10. Lentigen Licenses Fundamental Lentiviral Vector Technology Patent From the University of Cambridge
11. Genetic Engineering & Biotechnology News reports on cancer biomarkers
Post Your Comments:
(Date:11/25/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: ... prospects remain fundamentally strong and highlights the following ... received DSMB recommendation to continue the ZoptEC Phase ... the final interim efficacy and safety data ... men with heavily pretreated castration- and Taxane-resistant prostate ...
(Date:11/25/2015)... November 25, 2015 The ... is a professional and in-depth study on the ...      (Logo: ) , ... industry including definitions, classifications, applications and industry chain ... the international markets including development trends, competitive landscape ...
(Date:11/24/2015)... ... 24, 2015 , ... The United States Golf Association (USGA) today announced Dr. ... Award. Presented annually since 1961, the USGA Green Section Award recognizes an individual’s distinguished ... , Clarke, of Iselin, N.J., is an extension specialist of turfgrass pathology in ...
(Date:11/24/2015)... Nov. 24, 2015 /CNW/ - iCo Therapeutics ("iCo" or ... financial results for the quarter ended September 30, ... Canadian dollars and presented under International Financial Reporting ... ," said Andrew Rae , President ... iCo-008 are not only value enriching for this ...
Breaking Biology Technology:
(Date:11/17/2015)... Nov. 17, 2015 Pressure BioSciences, Inc. (OTCQB: ... development and sale of broadly enabling, pressure cycling technology ... industry, today announced it has received gross proceeds of ... Private Placement (the "Offering"), increasing the total amount raised ... more additional closings are expected in the near future. ...
(Date:11/11/2015)... Minn. , Nov. 11, 2015   MedNet Solutions ... entire spectrum of clinical research, is pleased to announce that ... in Clinical Trials (PCT) event, to be held November ... be able to view live demonstrations of iMedNet ... and learn how iMedNet has been able to ...
(Date:11/4/2015)... New York , November 4, 2015 ... to a new market report published by Transparency Market ... Share, Growth, Trends and Forecast 2015 - 2022", the global ... of US$ 30.3 bn by 2022. The market is ... the forecast period from 2015 to 2022. Rising security ...
Breaking Biology News(10 mins):